Drive DeVilbiss to discontinue CPAP line ‘The ability to transition the manufacturing space away from the CPAP lines allow us to raise our output of (oxygen)'
By HME News Staff
Updated 11:35 AM CDT, Thu September 2, 2021
PORT WASHINGTON, N.Y. – Drive DeVilbiss Healthcare will discontinue its DV5 and DV6 series of CPAP devices as of December 2021, citing raw material shortages, difficulty securing needed parts and increased component pricing.
The company will continue to focus on its oxygen products in response to the COVID-19 pandemic.
“Over the last two years, Drive DeVilbiss has been a major supplier of critical oxygen products during the largest respiratory pandemic in history,” said Derek Lampert, CEO. “It has been our duty to provide essential therapeutic oxygen products to the global market. We have taken that responsibility very seriously and have focused our resources to that end. With the most recent resurgence of COVID-19, we continue to run at maximum capacity. The ability to transition the manufacturing space away from the CPAP lines will allow us to raise our output of these critical medical devices.”
Drive DeVilbiss will no longer accept orders for the DV5 and DV6 series of CPAP devices, but it will continue to support warranty commitments on the devices and the sale of accessories such as chambers, filters and patient tubing to support continued therapy by users.
Comments